A combination medication: Buprenorphine (partial opioid agonist) and Naloxone (opioid antagonist).
Designed to reduce withdrawal symptoms and cravings associated with opioid addiction.
Approved by the FDA for the treatment of opioid dependence.
Trending now
Leave Your Comment